🔎 Trials Near Me

Home › Blood Cancers › Oklahoma › Oklahoma City

Blood Cancers clinical trials in Oklahoma City, OK

7 studies for Blood Cancers are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Mercy Hospital Oklahoma City, Oklahoma City
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

RecruitingObservational study
  • Mercy Hospital Oklahoma City, Oklahoma City
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • OU Health Stephenson Cancer Center, Oklahoma City
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

RecruitingPhase 2
  • OU Health Physicians - Infectious Disease Clinic, Oklahoma City
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT06665100

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • University of Oklahoma Health Science Center, Oklahoma City
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

RecruitingPhase 3
  • University of Oklahoma Health Sciences Center, Oklahoma City
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • OU Health Stephenson Cancer Center, Oklahoma City
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

Blood Cancers trials in other cities

Other studies in Oklahoma City

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.